A Phase II Open-Label Study of TPI 287 in Patients With Breast Cancer Metastatic to the Brain.
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2018
At a glance
- Drugs TPI 287 (Primary) ; Dexamethasone; Diphenhydramine; Ranitidine
- Indications Brain metastases; Breast cancer
- Focus Therapeutic Use
- 19 Apr 2017 Status changed from active, no longer recruiting to completed.
- 27 Sep 2016 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
- 22 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.